Stroke, Acute Clinical Trial
— RERCOfficial title:
Robotic Exoskeleton Gait Training During Acute Stroke Rehabilitation
Verified date | February 2021 |
Source | Kessler Foundation |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of this RCT is to explore the clinical, functional and neurophysiological effectiveness of RE-assisted (Robotic Exoskeleton) early intervention gait therapy in stroke patients during inpatient and outpatient stroke rehabilitation as compared to traditional gait training in three groups: 1) RE; 2) RE-Standard of Care (SOC) and 3) SOC. We will evaluate the short and long-term effects on functional mobility, clinical, neurophysiological, community participation and quality of life.
Status | Enrolling by invitation |
Enrollment | 96 |
Est. completion date | December 2022 |
Est. primary completion date | December 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years to 80 Years |
Eligibility | Inclusion Criteria: - Stroke survivors < 4 weeks from most recent stroke. - Age: 21- 80 years - Unilateral hemiparesis - Medical clearance by a Kessler Institute for Rehabilitation physician. - Be able to physically fit into the exoskeleton device. - Be able to tolerate upright standing for 30 minutes. - Have joint range of motion within normal functional limits for ambulation. - Have sufficient strength to use the hemiwalker, bilateral canes or walker while wearing the RE. - Have stable blood pressure; no diagnosis of persistent orthostatic hypotension (blood pressure drop of more than 30 millimeters of Mercury in body weight support system). - Patient cognitive status and ability to communicate in English must be at a level consistent with that required to participate in standard motor rehabilitation, e.g. can follow directions as determined by a Kessler Institute for Rehabilitation physician or physical therapist. - No history of injury or pathology to the unaffected limb. Exclusion Criteria: - Unable to physically fit within the RE: Height below 60" or above 76" and weight above 220 lbs. - Joint contracture or spasticity of any limb that limits normal ROM during ambulation with assistive devices. - Any medical issue that precludes full weight bearing and ambulation (e.g. orthopedic injuries, pain, severe spasticity). - Skin issues that would prevent wearing the device. - Pressure sore stage 2 or higher located in an area that would negatively affect weight bearing, harness fit, or therapist assistance. - Pre-existing condition that caused exercise intolerance.(Documented uncontrolled hypertension, coronary artery disease, cardiac arrhythmia, or congestive heart failure) - Hospitalization for heart attack, heart surgery or acute heart failure within 3 months of enrollment in study. - Severe cognitive or psychiatric problems as well as incontinence might be contraindications to start training with a RE. - History of severe cardiac disease such as myocardial infarction, congestive heart failure. - Uncontrolled seizure disorder. - Uncontrolled spasticity that would interfere with walking in the RENeuromuscular or neurological pathologies (e.g., Parkinson's disease, spinal cord injury, or traumatic brain injury with evidence of motor weakness and multiple sclerosis) that will interfere with neuromuscular function, ambulation, or limit the range of motion of the lower limbs - Orthopedic pathologies or history that will interfere with ambulation or limit the range of motion of the lower limbs (e.g., knee replacement, fixed contractures, inflammation) - Pregnant as confirmed by pregnancy test. |
Country | Name | City | State |
---|---|---|---|
United States | Kessler Foundation | West Orange | New Jersey |
Lead Sponsor | Collaborator |
---|---|
Kessler Foundation |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Functional Independence Measure (FIM) | a conventional assessment measure of motor function | 6 months | |
Primary | TUG | time up and go (TUG) test | 6 months | |
Primary | BBA | Berg Balance Assessment (BBA) | 6 months | |
Primary | ROM | range of motion (ROM)- conventional assessment performed by a physical therapist | 6 months | |
Primary | strength | conventional assessment performed by a physical therapist | 6 months | |
Primary | temporal spatial parameters | collected though motion capture camera system | 6 months | |
Primary | plantar loading | use of shoe insoles to gather information about foot pressure | 6 months | |
Primary | electromyography (EMG) | a measure of muscle activation (EMG signal) at different phases of gait cycle (swing versus double support). | 6 months | |
Primary | SIS | stroke impact scale (SIS). questionnaire about quality of life post-stroke | 6 months | |
Primary | LIFE-H | assessment of life habits (LIFE-H). questionnaire about quality of life post-stroke | 6 months | |
Primary | SSQoL | stroke specific quality of life scale (SSQoL). questionnaire about quality of life post-stroke | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05378035 -
DOAC in Chinese Patients With Atrial Fibrillation
|
||
Completed |
NCT03574038 -
Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke
|
N/A | |
Completed |
NCT03679637 -
Tablet-based Aphasia Therapy in the Acute Phase After Stroke
|
N/A | |
Completed |
NCT03633422 -
Evaluation of Stroke Patient Screening
|
||
Completed |
NCT04088578 -
VNS-supplemented Motor Retraining After Stroke
|
N/A | |
Not yet recruiting |
NCT05534360 -
Tenecteplase Treatment in Ischemic Stroke Registry
|
||
Withdrawn |
NCT04991038 -
Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients
|
N/A | |
Withdrawn |
NCT05786170 -
ERILs Und SNILs Unter SOC
|
N/A | |
Not yet recruiting |
NCT04105322 -
Effects of Kinesio Taping on Balance and Functional Performance in Stroke Patients
|
N/A | |
Recruiting |
NCT03132558 -
Contrast Induced Acute Kidney in Patients With Acute Stroke
|
N/A | |
Completed |
NCT02893631 -
Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke
|
||
Active, not recruiting |
NCT02274727 -
Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
|
||
Completed |
NCT02225730 -
Imaging Collaterals in Acute Stroke (iCAS)
|
||
Terminated |
NCT01705353 -
The Role of HMGB-1 in Chronic Stroke
|
N/A | |
Active, not recruiting |
NCT01581502 -
SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)
|
N/A | |
Completed |
NCT01182818 -
Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease
|
N/A | |
Completed |
NCT00761982 -
Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.
|
Phase 1/Phase 2 | |
Completed |
NCT00535197 -
Autologous Bone Marrow Stem Cells in Ischemic Stroke.
|
Phase 1/Phase 2 | |
Terminated |
NCT00132509 -
FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic Stroke
|
Phase 2 | |
Recruiting |
NCT05760326 -
Diagnostic and Prognostic Role of Clot Analysis in Stroke Patients
|